Mirvish S S, Huang Q, Ji C, Wang S, Park S S, Gelboin H V
Eppley Institute for Research in Cancer, University of Nebraska Medical Center, Omaha 68105.
Cancer Res. 1991 Feb 15;51(4):1059-64.
Inhibitory monoclonal antibodies (MAbs) were used to determine the contribution of epitope-specific cytochrome P-450 isozymes in rat liver microsomes to hydroxylation of the esophageal carcinogen methyl-n-amylnitrosamine. These P-450-catalyzed reactions form 2-, 3-, 4-, and 5-hydroxymethyl-n-amylnitrosamine, formaldehyde (demethylation), and pentaldehyde (depentylation). With uninduced microsomes from male rats, MAb 1-68-11 inhibited 4-hydroxylation by 73% and demethylation by 46%. This indicated the major contribution of constitutive male-specific P-450 IIC11 to the metabolism. Inhibition studies with MAbs 2-66-3 and 1-91-3 indicated that P-450 IIB1 contributed 19% and IIE1 35% to demethylation. With uninduced microsomes from females, MAb 1-68-11 produced similar inhibitions to those in male rats, indicating that female-specific P-450 IIC12 (which is closely related to IIC11) also catalyzed 4-hydroxylation and demethylation. With microsomes from 3-methylcholanthrene-induced male rats, P-450 IA1 and/or IA2 were responsible for 60% of 3-hydroxylation and 40% of depentylation. With microsomes from phenobarbital-treated rats, P-450 IIB1 and IIB2 catalyzed all 6 reactions but especially 4-hydroxylation and depentylation, which were 50-75% inhibited by MAb 2-66-3. Microsomes from Aroclor-induced males behaved as if they were induced by both 3-methylcholanthrene and phenobarbital. After treatment with isoniazid (a P-450 IIE1 inducer), inhibition by MAb 1-91-3 indicated a 45% contribution of P-450 IIE1 to demethylation, and both P-450 IIE1 and IIB1 (or IIB2) appear to have been induced. A major finding with uninduced microsomes was the high specificity of MAb 1-68-11 for inhibiting 4-hydroxylation, indicating that P-450 IIC11 and IIC12 catalyzed most of this omega-1-hydroxylation. In microsomes from induced rats, the MAb inhibitions showed the role of the induced P-450 IA1 (or IA2), IIB1 (or IIB2), and IIE1 in methyl-n-amylnitrosamine hydroxylation at different positions, as well as the presence of P-450 IIC11. This study illustrates the usefulness of inhibitory MAbs for defining the contribution of individual P-450s to position-specific metabolism.
使用抑制性单克隆抗体(MAb)来确定大鼠肝微粒体中表位特异性细胞色素P-450同工酶对食管癌致癌物甲基正戊基亚硝胺羟基化作用的贡献。这些P-450催化的反应生成2-、3-、4-和5-羟甲基正戊基亚硝胺、甲醛(去甲基化)和戊醛(去戊基化)。对于雄性大鼠的未诱导微粒体,单克隆抗体1-68-11可使4-羟基化反应抑制73%,去甲基化反应抑制46%。这表明组成型雄性特异性P-450 IIC11对代谢起主要作用。用单克隆抗体2-66-3和1-91-3进行的抑制研究表明,P-450 IIB1对去甲基化反应的贡献为19%,P-450 IIE1为35%。对于雌性大鼠的未诱导微粒体,单克隆抗体1-68-11产生的抑制作用与雄性大鼠相似,表明雌性特异性P-450 IIC12(与IIC11密切相关)也催化4-羟基化和去甲基化反应。对于3-甲基胆蒽诱导的雄性大鼠的微粒体,P-450 IA1和/或IA2负责60%的3-羟基化反应和40%的去戊基化反应。对于苯巴比妥处理的大鼠的微粒体,P-450 IIB1和IIB2催化所有6种反应,但尤其催化4-羟基化和去戊基化反应,单克隆抗体2-66-3可使其抑制50 - 75%。来自多氯联苯诱导的雄性大鼠的微粒体表现得好像同时受到3-甲基胆蒽和苯巴比妥的诱导。用异烟肼(一种P-450 IIE1诱导剂)处理后,单克隆抗体1-91-3的抑制作用表明P-450 IIE1对去甲基化反应的贡献为45%,并且P-450 IIE1和IIB1(或IIB2)似乎都被诱导了。未诱导微粒体研究的一个主要发现是单克隆抗体1-68-11对抑制4-羟基化反应具有高度特异性,这表明P-450 IIC11和IIC12催化了大部分这种ω-1-羟基化反应。在诱导大鼠的微粒体中,单克隆抗体的抑制作用显示了诱导的P-450 IA1(或IA2)、IIB1(或IIB2)和IIE1在甲基正戊基亚硝胺不同位置羟基化反应中的作用,以及P-450 IIC11的存在。这项研究说明了抑制性单克隆抗体在确定单个P-450对位置特异性代谢贡献方面的有用性。